Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for p

来源 :世界胃肠病学杂志:英文版(电子版) | 被引量 : 0次 | 上传用户:valerianforever
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To evaluate the feasibility of a new strategy of endoscopic variceal ligation combined with partial splenic embolization (EVL-PSE) for patients with cirrhosis and portal hypertension. METHODS: From May 1999 to May 2002, 41 cases with cirrhosis and po
其他文献
AIM: To study the effect of cyclin G2 on proliferation of gastric adenocarcinoma cell line-SGC-7901 cell in vitro.METHODS: By use of cation lipofectamine transf
党的十一届三中全会以来,我国在国有企业改革方面先后采取了一系列措施,这些改革措施对增强企业活力,转变企业经营机制起到了一定的作用,企业自主权有不同程度的扩大,指令性
2012年,有可能成为2008年以来中国公司赴美上市步伐最缓慢的一年。截止目前,已有四家中国公司推迟或取消IPO,登陆美国IPO市场的中国公司只有两家。国内市场IPO窗口虽然开启,
AIM: To investigate the expression of annexin I in pancreatic cancer and its relationship with the clinicopathologic factors,and to evaluate its potential clini
AIM:To investigate the inhibitory effect of dietary and medicinal formula Ganfujian granule on diethylnitrosamine (DEN)-induced hepatocarcinoma in rats.METHODS:
AIM: To observe the protective effect of heat shock protein 72 (HSP 72) induced by pretreatment of doxorubicin (DXR) on long-term cold preservation injury of ra
AIM:To detect the origin of hepatocellular carcinoma (HCC)recurring and attempt to propose a new recurrent mechanism.METHODS:Orthotopic liver allotransplantatio
阿尔斯通公司(以下简称“阿尔斯通”)是世界500强企业,成立于1928年,总部位于法国,经营业务以轨道交通、电力设备和电力传输基础没施为主。其司库体系经历了隶属财务部门,后独立成
AIM: To examine the calcium metabolism of colorectal cancer (CRC) in patients with colorectal cancer and control patients.METHODS: Seventy newly diagnosed CRC p
AIM: To investigate the expression of gonadotropin-releasing hormone (GnRH) receptor and the effects of GnRH analog(alarelin) on proliferation of cultured gastr